In the US, Cefotetan (cefotetan systemic) is a member of the drug class second generation cephalosporins and is used to treat Bacterial Infection, Bone infection, Cesarean Section, Cholecystitis, Intraabdominal Infection, Joint Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Skin or Soft Tissue Infection, Surgical Prophylaxis and Urinary Tract Infection.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
- Cefotetanum (Latin)
- Cefotetan (German)
- Céfotétan (French)
- Cefotetán (Spanish)
- Cefotetan (OS: BAN, USAN, DCIT, JAN)
- Céfotétan (OS: DCF)
- ICI 156834 (IS: Zeneca)
- Cefotetan (PH: JP XVI, USP 38)
- Cefotetan Disodium (OS: USAN)
- Cefotetan Sodium (OS: JAN)
- YM 09330 (IS: Yamanouchi)
- Cefotetan Disodium (PH: USP 38)
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|DCIT||Denominazione Comune Italiana|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.